Female identity in the three lays by Shakespeare: Othello, Romeo and Juliet, and A Midsummer Night's Dream
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
This thesis aims to analyze the structure of female identity in Shakespeare?s Othello, Romeo and Juliet, and A Midsummer Night?s Dream. After locating woman in the historical context of the Elizabethan period, it aims to explore the extent to which Shakespeare reflects the common beliefs about womanhood in his age and the question as to whether his female characters are conventional or unconventional according to contemporary norms. The main target of the thesis is to prove that female identity is mostly a male construct and that Shakespeare simultaneously subverts and approves the conventional norms in an ambivalent manner. This thesis includes striking examples from the plays which prove the fact that woman was seen as being subordinate and inferior to men, as reflected in the common stereotypical epithet of `the weaker vessel?. However, at the same time, Shakespeare seems to question this assumption and to project an image of femininity which opens it to debate.
Author
Elif Batu İncekara
Institution
How to Cite
Elif Batu İncekara (Master Thesis). Female identity in the three lays by Shakespeare: Othello, Romeo and Juliet, and A Midsummer Night's Dream, 2010, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- The relationship between mindfulness and sleep quality: The mediating role of smartphone addiction and bedtime procrastination(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)
- Declaration obligation of the insurant during the conclusion of the contract(2021)